| Trial ID: | L1350 |
| Source ID: | NCT00719316
|
| Associated Drug: |
Aliskiren
|
| Title: |
Aliskiren and Muscle Sympathetic Nerve Activity
|
| Acronym: |
MSNA
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Hypertension|Muscle Sympathetic Nerve Activity
|
| Interventions: |
DRUG: Aliskiren
|
| Outcome Measures: |
Primary: Normalisation of muscle sympathetic nerve activity, 1 year | Secondary: Blood pressure and Blood tests, 1 year
|
| Sponsor/Collaborators: |
Sponsor: UMC Utrecht
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-07
|
| Completion Date: |
2010-01
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-14
|
| Locations: |
University Medical Center utrecht, Utrecht, 3584CX, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00719316
|